Boundless Bio, Inc. Common Stock / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) N/A N/A N/A N/A N/A
    (estimated) €0.00 +NaN% -€44.37M -10.5% N/A N/A N/A
    (estimated) €0.00 +NaN% -€49.59M +0.8% N/A N/A N/A
    (estimated) €0.00 +NaN% -€49.19M -12.7% N/A N/A N/A
    €0.00 +NaN% -€56.38M +32.2% N/A -€50.29M +26.1% N/A
    €0.00 +NaN% -€42.64M +7.7% N/A -€39.87M +20.0% N/A
    €0.00 +NaN% -€39.59M +82.1% N/A -€33.24M +81.6% N/A
    €0.00 +NaN% -€21.75M -80.4% N/A -€18.30M -78.0% N/A
    €0.00 +NaN% -€111.12M +42.8% N/A -€83.13M +25.2% N/A
    €0.00 +NaN% -€77.84M +51.2% N/A -€66.38M +137.8% N/A
    €0.00 -€51.47M N/A -€27.92M N/A

    Notifications